The Company continues to gain significant positive commercial market traction with its first U.S. Food and Drug Administration ("FDA")-cleared product, Perimeter S-Series: Q1-2025 revenue of $550,269, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results